The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit
later.
We apologize for any inconvenience caused
ji xing que xue xing zu zhong jing mai rong shuan ji xue guan nei zhi liao yan jiu jin zhan
Author(s): WANG Meng, ZHOU Junshan, WU Aoyan
Pages: 391-
395
Year: 2017
Issue:
5
Journal: Chinese Journal of Neurology
Abstract: 脑卒中是我国居民死亡或致残的首要病因,其中缺血性卒中约占80%,急性期的治疗对脑卒中患者的预后极为重要.国内外指南均推荐在患者发病45h内采用重组组织型纤溶酶原激活剂(recombinanttissueplasminogenactivator,rt-PA)静脉溶栓为治疗急性缺血性卒中(acuteischemicstroke,AIS)的首选方法[1].然而经循证医学证实,能在时间窗内到达医院并具备溶栓适应证的患者非常有限,且大血管闭塞性脑卒中在静脉溶栓后能实现血管再通的比例偏低[2].在此背景下,近年来多模式血管再通方法应运而生.我们针对AIS血管再通治疗的研究进展进行综述,旨在提高临床医师对该治疗方法的认识,以利于对AIS患者进行个体化治疗.
Citations
No citation found
Related Articles
No related articles found